Arboreal will deploy the capital to expand its manufacturing capacity, strengthen R&D capabilities, and accelerate the commercialisation of its next generation of functional ingredients
| Photo Credit:
iStockphoto
Arboreal Bioinnovations Private Ltd, a specialty food and nutraceutical ingredients technology company said Thursday that it has raised ₹230 crore in a Series A funding round. EAAA, the alternatives arm of Edelweiss, led the funding round, with participation from Omnivore and continued backing from existing investor Rainmatter by Zerodha.Arboreal said it will deploy the capital to expand its manufacturing capacity, strengthen its research and development capabilities, and accelerate the commercialisation of its next generation of functional ingredients.Swati Pandey, Co-Founder and CEO, Arboreal Bioinnovations, said, “This fundraise is a strong validation of the direction we are taking as a company. It gives us the fuel to accelerate our mission of building clean, science-led solutions that address some of the world’s most pressing nutritional and food challenges, with innovation originating in India and reaching consumers globally.”Arboreal said it has built a differentiated “contextual innovation” model focused on developing ingredient solutions for the specific nutritional, functional, sensory and commercial requirements of Indian consumers and brands. This approach has enabled hundreds of emerging and challenger brands to launch category-defining products and scale rapidly across the food, beverage and nutraceutical markets.The company’s integrated ingredient technology platform brings together ingredient engineering, process research and development, formulation science and precision manufacturing. Arboreal has developed and commercialised proprietary ingredients across next-generation proteins, cocoa-based ingredients, natural zero-calorie sweeteners and functional fibres, with several additional ingredient platforms currently under development. Arboreal’s portfolio of “better-for-you” ingredients and its “ingredient-first innovation” model have supported more than 300 product launches across over 1,100 consumer brands and nutraceutical manufacturers during the past 18 months.Manish Chauhan, Co-Founder and COO, Arboreal Bioinnovations, said, “The confidence shown by EAAA, Omnivore and Rainmatter validates both the strength of our platform and the opportunity ahead of us. It gives us the ability to invest more deeply in science, manufacturing, talent and long-term innovation, while building a platform capable of creating differentiated ingredients for some of the world’s most important food and nutraceutical brands. We are excited to build Arboreal into a globally respected ingredient technology company from India.”Ashish Agarwal, Managing Director, Private Equity, EAAA Alternatives, said “The investment in Arboreal reflects the core philosophy of our fund’s strategy -- backing businesses with the potential to emerge as category leaders. As the first investment from our Discovery Fund II, we are particularly excited at the long-term growth prospects of Arboreal’s next-generation yeast protein products.”Jinesh Shah, Managing Partner at Omnivore, said, “The shift toward clean-label and functional foods requires engineered ingredients that deliver clear health benefits without sacrificing taste or margins. Arboreal fills a critical market gap with locally developed formulations. From sweetener alternatives to novel yeast proteins and collagens, Arboreal’s R&D stack positions them to power the next wave of health and wellness brands.”Published on July 30, 2026
